High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors
about
Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoproteinPotential role of the interaction between equine estrogens, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) in the prevention of coronary heart and neurodegenerative diseases in postmenopausal womenHDL enhances oxidation of LDL in vitro in both men and womenClinical Relevance of Biomarkers of Oxidative StressAntioxidant defenses in rat intestine and mesenteric lymphA high throughput biochemical fluorometric method for measuring lipid peroxidation in HDLNon-antioxidant properties of α-tocopherol reduce the anticancer activity of several protein kinase inhibitors in vitroAcrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.Oxidative risk for atherothrombotic cardiovascular disease.Dysfunctional HDL as a diagnostic and therapeutic targetHigh density lipoproteins (HDL) and the oxidative hypothesis of atherosclerosis.Elevated plasma albumin and apolipoprotein A-I oxidation under suboptimal specimen storage conditions.Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathwayHDL inhibits the effects of oxidized phospholipids on endothelial cell gene expression via multiple mechanismsChronic alcohol exposure increases circulating bioactive oxidized phospholipids.Older plasma lipoproteins are more susceptible to oxidation: a linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease.Intact human ceruloplasmin oxidatively modifies low density lipoprotein.Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway.Anti-oxidant properties of high-density lipoprotein and atherosclerosisDo free radicals play causal role in atherosclerosis? Low density lipoprotein oxidation and vitamin E revisited.Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.Pilot study for the establishment of biomarkers for radiation damage after computed tomography in childrenSignificant association between fluctuations in serum urate and high density lipoprotein cholesterol during exhaustive training.Are Reliable Change (RC) calculations appropriate for determining the extent of cognitive change in concussed athletes?Electrospray MS/MS reveals extensive and nonspecific oxidation of cholesterol esters in human peripheral vascular lesions.In vivo changes in plasma coenzyme Q10, carotenoid, tocopherol, and retinol levels in children after computer tomography.A biochemical fluorometric method for assessing the oxidative properties of HDL.Analysis of circulating lipid-phase micronutrients in humans by HPLC: review and overview of new developments.Coenzyme Q10, carotenoid, tocopherol, and retinol levels in cord plasma from multiethnic subjects in Hawaii.In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide.Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL.Burn and smoke inhalation injury in sheep depletes vitamin E: kinetic studies using deuterated tocopherols.Oxidized low-density lipoprotein.Serum amyloid A in uremic HDL promotes inflammationMolecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease.gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications.Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity.Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BIHigh-density lipoproteins: an emerging target in the prevention of cardiovascular disease.Glycoxidized HDL, HDL enriched with oxidized phospholipids and HDL from diabetic patients inhibit platelet function.
P2860
Q24294419-592FA411-DED9-41EB-B7CF-E872F665F987Q24800416-815CA065-77DA-417C-A670-8E4EBF0162F6Q24810947-651E82F7-2E59-4051-BA0B-82CCBA58AA48Q26785512-DFBE2CFD-D40B-49DB-8480-45677032E617Q28373165-1289C0A1-F040-4159-B3EE-F5313E0527CBQ28544713-73041579-AEAD-4E40-A2AD-EBCAE4E443E9Q28730066-C8DA69A6-5944-469C-B1E9-10F026C21FC2Q33222417-E9803216-25EA-421C-822F-97FF193F9342Q33554184-32D7C994-FBB4-46F7-9361-9D11E14A83FFQ33604003-AAAF48D5-924B-44A8-AE6F-CFC3D676FC84Q33806840-1EDAC7AC-0432-4A3E-836F-4B39B4D8A7DBQ33850682-6AACD822-48C9-4027-BF55-27DD014C097AQ33897803-41A035AD-6CCD-4E1F-B96A-68379C1A4A8BQ33945091-FF22B2E8-8BA1-481A-94BC-562FFF71BB6DQ33991026-C53738A2-258F-4CFD-8A2A-F026A5AE4E9EQ34057653-0EC33485-02DC-4938-812E-F4B21BFD588AQ34138265-663B5EF4-4CC1-4D4F-A89A-F8EBE54EB39EQ34145731-57A2CAAF-E992-4862-B49E-279C6D655FB8Q34440172-C0F8294D-B2D7-4493-A9D1-E5F2E22C3F4BQ34496407-46A4E942-2328-4382-A403-3B64E79F8BAEQ34651427-8581CE9A-AB8B-4D42-9DA6-4A9E6D4116DBQ35189126-0B254301-7B97-457E-9CB4-6F22A3FE1B25Q35326807-4F72FC5D-44DF-42FF-9534-7D2F9C798E3EQ35327007-4852EDC8-5D86-4D22-B71B-8D988F36C7E6Q35380259-E9472FEA-1342-4C4A-83E8-6B55562384EFQ35524214-CA2538C2-658E-4855-8CBF-19440FF909A1Q35562004-5E9A856A-5A5B-4326-8634-DADB63A66077Q35629514-317019A3-83A5-4943-9051-713CB73D685AQ35629622-FC62DFC7-E505-4F95-913A-A106D5991405Q35760064-15C007CE-4E24-4EA2-AD96-1F256BB3AE5BQ35783321-DF3404C3-5EDD-44AF-B569-AD8C6A1DC4E6Q35855647-306BD483-D402-4A66-9776-C2A38F04984BQ35860737-EE155B64-6A70-4CDD-9BA1-F7778947450EQ35917487-99ED967C-1757-44E7-A601-A61D3CF80242Q36037988-2FD06389-A875-4009-937E-987D8FB9BB2AQ36083550-BF240B1B-8039-481D-83EE-96BC9B1B5FA5Q36130121-F903A97C-9B58-4940-BB3C-B71F35BF7785Q36445823-C6DE7721-37F0-44BB-93B4-8A5585114DC0Q36611036-B7550C9E-E1D1-41A3-988B-B32377B4B1F1Q36718110-BD74F3C7-FD99-4618-87A3-DDD4ACB76FCB
P2860
High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
High density lipoprotein is th ...... ood plasma from fasting donors
@en
High density lipoprotein is th ...... od plasma from fasting donors.
@nl
type
label
High density lipoprotein is th ...... ood plasma from fasting donors
@en
High density lipoprotein is th ...... od plasma from fasting donors.
@nl
prefLabel
High density lipoprotein is th ...... ood plasma from fasting donors
@en
High density lipoprotein is th ...... od plasma from fasting donors.
@nl
P2093
P2860
P356
P1476
High density lipoprotein is th ...... ood plasma from fasting donors
@en
P2093
P2860
P304
10316-10320
P356
10.1073/PNAS.89.21.10316
P407
P577
1992-11-01T00:00:00Z